Singapore’s Bet on Conservation Biotechnology Aims to Preserve the Living

Published by Biotech Connection Singapore on

By Dr Zheng-Shan Chong

Collecting and preserving tissue has enabled major medical breakthroughs for human health. Could it do the same for endangered wildlife?

Sunda Pangolins are one of the most endangered species in Southeast Asia. Photo by: Zaharil Dzulkafly, IUCN SSC Pangolin Specialist Group

Collecting and storing biological samples isn’t new to science; it has been a cornerstone of research for over a century. For example, organisations like Seed Savers Exchange conserve and share heirloom seeds to protect plant biodiversity and support sustainable agriculture. Similarly, biobanks like UK Biobank store human samples, helping scientists discover new treatments for cancer, heart disease, and many other conditions.

At Mandai Nature, the conservation arm of Mandai Wildlife Group, a small group of scientists is applying a similar concept to wildlife. By collecting and cryopreserving biological samples from endangered animals, they aim to preserve genetic diversity and lineages of threatened species from around the region, supporting long-term conservation planning.

“Human activity has accelerated species extinction rates to as much as 1,000 times higher than before our time,” explains Dr Oz Pomp, who leads the initiative. “Conservation biotechnology offers us powerful tools to safeguard biodiversity and help us save species.”

Unlike some approaches that focus on “bringing back” extinct species using genetic engineering, this initiative prioritises preserving live cells from as many donors as possible to capture the full genetic diversity of a species such as the critically endangered Sunda pangolin and the Celebes crested macaque. As one of the first in Southeast Asia, this biobank also includes induced pluripotent stem cells (iPSCs) derived from live cells of selected species, which hold great potential for conservation and zoological research.

How does Biobanking work?

The process is straightforward. From live animals, samples are collected through minimally invasively procedures which then are cryopreserved in the lab. The scientists also take the opportunity to collect as many samples as possible from wildlife that have died i.e. from natural causes or after unfortunate incidences like road accidents.

Some of the samples taken require a little more work; for instance, iPSCs are derived from primary tissue using safer, non-integrated reprogramming, which do not alter the genome or leave foreign genetic material in the resulting cells.

“We do not do any genetic engineering,” says Dr Pomp, “the aim is to preserve natural genetic diversity rather than alter the species’ genetic identity.”

At Mandai Nature, scientists collaborate with the Mandai Wildlife Group to isolate and cryopreserve biological samples collected from animals in the care of Singapore’s zoos, as well as from rescued wildlife brought to the Group’s animal hospital. Photo credit: Mandai Nature

Maintaining genetic diversity is a key challenge for endangered species, which are vulnerable to genetic bottlenecks and inbreeding. Cheetahs, for example, are over 90% homozygous, leaving them prone to disease, reproductive issues, and with a reduced adaptability to environmental changes.

Biobanking offers a lifeline to increase the natural genetic diversity of an animal population. The Frozen Zoo in San Diego contains over 10,000 living cell cultures, oocytes, sperm, and embryos representing nearly 1,000 taxa, which are used for breeding and reintroduction programs, biological research, and facilitating anti-poaching regulations.

iPSCs also offer exciting possibilities, says Dr Pomp. Since iPSCs can be differentiated into any cell type, there could be future potential to make gametes – sperm and egg cells – and use assisted reproduction technologies to birth individual animals without cloning. Cellular agriculture, where cruelty-free animal products are grown in the lab, could be another interesting application, as it could help reduce poaching and alleviate pressure on endangered species.

But until these technologies are ready, the organisation will focus its efforts on biobanking and research. Dr Pomp welcomes collaborations from interested labs and biotechs, as he sees the biobank as a resource to advance wildlife research.

More than just wildlife – The real-world benefit of biodiversity

Preserving endangered species isn’t just about sentimentality; it’s a strategic move to maintain ecological balance. Southeast Asia is a global biodiversity hotspot, known for its rich variety of animals, insects, plants, and unique ecosystems that sustain them. Although ASEAN nations cover 3% of the Earth’s land area, they are home to 20% of all known species of the world. Unfortunately, the region also faces stark conservation challenges, with the highest proportion of Critically Endangered vertebrate species.

Studies have shown that higher biodiversity enhances ecosystem resilience, allowing species within them to better cope with environmental changes and continue sustaining the human communities that rely on them. Apart from the biobanking initiative, Mandai Nature supports over 50 other wildlife conservation projects focused on protecting threatened species and restoring habitats in Singapore and Southeast Asia.

The funding challenge – Who invests in the future?

The cost of maintaining biobanks like Mandai Nature’s isn’t trivial. Unfortunately, conservation biotechnology doesn’t attract nearly as much funding as other areas like medicine or manufacturing. Pharmaceutical biotech startups can raise large amounts on the promise of outsized future returns; for instance, Singapore startup Callio Therapeutics recently closed a US$187 million Series A round to advance novel cancer therapies to the clinic. In contrast, companies finding alternative ways to grow cruelty-free animal products, like cultivated leather, typically raise funding rounds of an order of magnitude lower.

For Mandai Nature, the biobanking initiative represents a key component of their efforts to conserve biodiversity in Southeast Asia. With live cells banked from more than 90 species and counting, Dr Pomp is quietly enthusiastic about the future for conservation biotechnology and hopes that more will share his vision.

“We are not bringing back the past,” he says, “we’re protecting what we still have, for the future.”


Acknowledgement: We thank Dr Li Shengnan for her contribution in the copy editing of this piece.

Biotech Connection Singapore (BCS) is part of an international network of non-profit organizations, that aims to promote the transfer of ideas from theory to real world applications by providing a platform for fostering interaction between academia, industry and businesses.